Abstract
AbstractAchondrogenesis type II (ACG2) is a lethal skeletal disorder caused by pathogenic variants in COL2A1. We present a fetus with cystic hygroma and severe shortening of the limbs at 14 weeks of gestation. We performed postnatal genetic analysis of the parents and fetus to diagnose the disease. A novel missense variant of COL2A1 [NM_001844.5: c.2987G>A, (p. Gly996Asp)] was identified, which led to the ACG2 diagnosis.
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Biochemistry
Reference11 articles.
1. Kannu, P., Bateman, J. & Savarirayan, R. Clinical phenotypes associated with type II collagen mutations. J. Paediatr. Child Health 48, E38–E43 (2012).
2. Mortier, G. R. et al. Nosology and classification of genetic skeletal disorders: 2019 revision. Am. J. Med. Genet. A 179, 2393–2419 (2019).
3. Sasahara, J. et al. Prenatal diagnosis of a rare skeletal dysplasia by three-dimensional computed tomographic imaging: Achondrogenesis type I. J. Jpn. Soc. Perinat. Neonatal Med. 50, 1336–1340 (2015).
4. Sato, T. et al. Novel TFAP2A mutation in a Japanese family with branchio-oculo-facial syndrome. Hum. Genome Var. 5, 5 (2018).
5. Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献